ArticleJournal for immunotherapy of cancer2021

Selectively targeting myeloid-derived suppressor cells through TRAIL receptor 2 to enhance the efficacy of CAR T cell therapy for treatment of breast cancer.

Saisha A Nalawade et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.